{ "@context": "https://schema.org", "@type": "Dataset", "name": "Boise Standard Entity: reblozyl.bmshealthcare.jp", "url": "https://boisestandard.org/web/reblozyl-bmshealthcare-jp", "identifier": "bs-9d819fc5", "datePublished": "2026-07-11T15:17:29.970969+00:00", "description": "Boise Standard machine-readable entity profile for reblozyl.bmshealthcare.jp. Schema.org coverage graph, six-layer topology fingerprint, ratio signals, Root-LD anchor. Full provenance.", "license": "https://creativecommons.org/publicdomain/zero/1.0/", "isAccessibleForFree": true, "creator": { "@type": "Organization", "name": "Boise Standard", "url": "https://boisestandard.org" }, "about": { "@type": "WebSite", "url": "https://www.reblozyl.bmshealthcare.jp/", "name": "レブロジル®製品情報サイト｜ブリストル・マイヤーズ スクイブ株式会社" }, "variableMeasured": [ { "@type": "PropertyValue", "name": "federationId", "value": "bs-9d819fc5" }, { "@type": "PropertyValue", "name": "schemaTypes", "value": "" }, { "@type": "PropertyValue", "name": "schemaCoverageScore", "value": "0.0" }, { "@type": "PropertyValue", "name": "topologyFingerprint", "value": "computed" }, { "@type": "PropertyValue", "name": "topologyModelVersion", "value": "1.0.0" }, { "@type": "PropertyValue", "name": "textLengthCategory", "value": "long" }, { "@type": "PropertyValue", "name": "typeTokenRatio", "value": "0.2279" }, { "@type": "PropertyValue", "name": "nonAsciiRatio", "value": "0.5248" }, { "@type": "PropertyValue", "name": "hapaxLegomenaRatio", "value": "0.1362" }, { "@type": "PropertyValue", "name": "javascriptSurfaceRatio", "value": "0.0" }, { "@type": "PropertyValue", "name": "navRatio", "value": "0.345" }, { "@type": "PropertyValue", "name": "securityLabel", "value": "STRONG" }, { "@type": "PropertyValue", "name": "freshnessLabel", "value": "CURRENT" }, { "@type": "PropertyValue", "name": "interiorPagesCrawled", "value": "15" }, { "@type": "PropertyValue", "name": "mintedAt", "value": "2026-07-11T15:17:29.970969+00:00" }, { "@type": "PropertyValue", "name": "specVersion", "value": "Root-LD v1.0" }, { "@type": "PropertyValue", "name": "entityType", "value": "domain" }, { "@type": "PropertyValue", "name": "detectedLanguage", "value": "ja" }, { "@type": "PropertyValue", "name": "hasGeo", "value": "False" }, { "@type": "PropertyValue", "name": "hasAtomicAnswer", "value": "False" } ], "root_ld": { "anchor": { "uuid": "9d819fc5-ff1d-4dcd-9aac-51a609fd08c4", "federation_id": "bs-9d819fc5", "sequence": 0, "content_hash": "e41fe8414eb31c9d61a042583bb1f351bb275f6696b43386ce671d014674405c", "primary_source": "https://www.reblozyl.bmshealthcare.jp/", "source_verified": true, "generation_method": "crawl_extract_v1", "spec_version": "1.0", "queued_at": "2026-05-26T20:35:49.688622+00:00", "minted_at": "2026-07-11T15:17:29.970969+00:00" }, "body": { "domain": "reblozyl.bmshealthcare.jp", "canonical_url": "https://www.reblozyl.bmshealthcare.jp/", "tld": "jp", "slug": "reblozyl-bmshealthcare-jp", "status_code": 200, "redirect_chain": [], "response_time_ms": 6244, "ssl_valid": true, "server_header": "Apache", "title": "レブロジル®製品情報サイト｜ブリストル・マイヤーズ スクイブ株式会社", "h1": "", "meta_description": "骨髄異形成症候群（MDS）に伴う貧血に対する治療薬であるレブロジル®（一般名 ルスパテルセプト(遺伝子組み換え)）に関する情報を医療関係者向けに提供しています。", "lang_declared": "ja", "schema_types": [], "schema_score": 0.0, "schema_prop_count": 0, "schema_gap_list": [], "top_semantic_words": [ "mds", "login", "bms", "code", "doccheck", "inami", "healthcare", "bristol", "myers", "squibb", "affiliate", "subsidiary", "error", "success", "foot", "note", "heading", "ace", "failed", "load", "cookies", "link", "seminar", "members", "cookie", "evolving", "future", "clicking", "preferences", "ctcae", "class", "txt", "pick", "contents", "lecture", "demand", "movie", "news", "enabled", "default" ], "ratio_signals": { "schema_density": 0.0, "nav_ratio": 0.3448, "content_to_structure_ratio": 0.007402, "external_tld_diversity": 2, "self_declaration_coherence": 0.0, "schema_to_navigation_alignment": 0.0, "javascript_surface_ratio": 0.0, "url_depth_distribution": { "depth_0": 2, "depth_1": 4, "depth_2": 9, "depth_3plus": 14 } }, "semantic_html_ratio": 0.0, "javascript_surface_ratio": 0.0, "img_alt_coverage": 0.0, "robots_complexity_score": 0, "ariadne_blocked": false, "security_label": "STRONG", "https_enforced": true, "freshness_label": "CURRENT", "tld_starjet_url": "https://boisestandard.org/registry/tld/ledger/jp", "schema_starjet_urls": [], "native_text_sample": "製品情報\n臨床成績\n安全性・適正使用情報\nオンデマンド動画\nWebセミナー・学会共催セミナー\nPick up contents\n\nピックアップコンテンツ\n\n低リスクMDSに伴う貧血治療の課題とレブロジルという治療選択肢\n\nCOMMANDS試験\n\n用量調節\n\nWeb seminar\n\nレブロジル®︎のWebセミナー・学会共催セミナー\n\nLR-MDS Web Seminar\n-Evolving for the Future-\n\n開催日 :\n\n2026.07.17（金）18:30～19:10\n\n座長 :\n\n医療法人菊郷会 愛育病院 副院長　近藤 健 先生\n\n講演 :\n\n演題：『輸血非依存を狙ったLuspaterceptの\n　 　 　もたらす力\n　 　 　～LR-MDSの生存期間延長を求めて～』\n演者：近畿大学医学部 血液・膠原病内科 准教授\n　　　森田 泰慶 先生\n\nMembers Only\n\n血液疾患\n\nLR-MDS Web Seminar\n-Evolving for the Future-\n\n開催日 :\n\n2026.07.21（火）18:30～19:10\n\n講演1 :\n\n演題：MDSと心", "topology_fingerprint_version": "1.0.0", "entity_type": "domain", "geo": { "address": "", "latitude": null, "longitude": null, "place_id": "", "category": "", "jurisdiction_path": "", "provenance_source": "", "fetched_at": "" }, "atomic_answer": "" }, "recursive": { "edges": [], "appended_at": [], "edge_count": 0 } }, "topology_fingerprint_summary": { "model_version": "1.0.0", "text_length_category": "long", "raw_text_length": 19407, "extracted_text_hash": "4d664e862f2548679ef1aa9dae231108b153901b29e87e660eb43e084b4c8c4f", "detected_language": "ja", "entity_type": "domain", "type_token_ratio": 0.227903, "non_ascii_ratio": 0.524811, "character_entropy": 5.171644, "hapax_legomena_ratio": 0.136168, "hapax_to_type_ratio": 0.597484, "comma_to_period_ratio": 0.036, "repetition_score": 0.863832 }, "schema_graph_summary": { "declared_types": [], "parent_types": [], "sibling_types": [], "child_types": [], "negative_space": [ "Action", "BioChemEntity", "CreativeWork", "Event", "Intangible", "MedicalEntity", "Organization", "Person", "Place", "Product" ] } }